Recent Stages I-III Rectal Cancer News

Addition of Eloxatin® Following Surgery Delays Cancer Progression in Certain Colorectal Cancers

(July 28, 2016)

The addition of the chemotherapy combination consisting of Eloxatin (oxalipatin) plus 5-fluorouracil (5 FU) following surgery reduces the risk of cancer progression among patients with deficient mismatch... Continue Reading

Vectibix® Improves Survival in Colorectal Cancer, Demonstrates Importance of Tissue Testing

(January 28, 2016)

The addition of Vectibix® (panitumumab) to best supportive care improves survival over best standard care alone among colorectal cancer patients who have stopped responding to chemotherapy. However, the... Continue Reading

FOLFOX Improves Disease-Free Survival in Stage II and III Rectal Cancer Patients

(June 11, 2014)

Researchers at the University of Ulsan College of Medicine in South Korea reported that treatment with the FOLFOX chemotherapy regimen in rectal cancer patients improved 3-year disease-free survival over... Continue Reading

Aspirin May Prolong Life in PIK3CA-Mutated Colorectal Cancers

(November 6, 2012)

Daily aspirin use improves survival among patients with mutated-PIK3CA colorectal cancer, according to the results of a study published in the New England Journal of Medicine. Colorectal cancer remains... Continue Reading

Adjuvant Therapy May Offer Survival Benefit in Older Patients with Colorectal Cancer

(September 11, 2012)

Adjuvant chemotherapy appears to offer a survival benefit to patients aged 75 years or older who have surgically resected colorectal cancer, according to the results of a study published in the Journal... Continue Reading

Rectal Cancer Patients May Benefit from Higher Dose of Preoperative Radiation

(October 12, 2011)

Among rectal cancer patients treated with chemotherapy and radiation therapy prior to surgery, providing a higher dose of radiation therapy (50 Gy rather than 45 Gy) may reduce the risk of cancer recurrence.... Continue Reading

African Americans Most Willing to Exhaust Resources for Life-Extending Care

(May 5, 2011)

African Americans who are diagnosed with lung or colorectal cancer may be more willing than Whites to expend all personal financial resources in order to extend their lives. Other minority groups also... Continue Reading

Pathological Complete Response Predicts Better Outcomes in Locally Advanced Rectal Cancer Patients

(August 25, 2010)

Among patients with locally advanced rectal cancer, a complete disappearance of detectable cancer (pathological complete response) after preoperative chemoradiation therapy is linked with better long-term... Continue Reading

Antibiotic Sponge Ineffective at Preventing Surgical Infection

(August 12, 2010)

Patients undergoing colorectal surgery are reported to experience an increased incidence of surgical-site infection with the addition of a gentamicin-collagen sponge enclosed at the surgery site. These... Continue Reading

Most Survivors of Lung and Colorectal Cancer Keep Their Jobs

(April 15, 2010)

Among people diagnosed with nonmetastatic lung or colorectal cancer, the majority return to work, according to a study recently published in Journal of Clinical Oncology. Those who do leave the workforce... Continue Reading

Next Page »